Piper Jaffray analyst Sean Wieland recommends using the post-earnings selloff yesterday in shares of Medidata Solutions as a buying opportunity. The analyst views the pullback as overdone and reiterates an Overweight rating on the stock with a slightly reduced price target of $96. Contract timing and the addition of Shyft will accelerate backlog and subscription revenue in the second half of 2018 and continue into 2019, Wieland tells investors in a research note.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.